Silibinin Protects Against Isoproterenol-Induced Rat Cardiac Myocyte Injury Through Mitochondrial Pathway After Up-regulation of SIRT1

Terminally differentiated adult injured cardiac myocytes have been used for various animal models of heart failure. It has recently been shown that isoproterenol induces injury in rat neonatal cardiac myocytes via a β-adrenergic pathway, suggesting that it might be one of the factors involved in myo...

Full description

Bibliographic Details
Main Authors: Bei Zhou, Li-Jun Wu, Lin-Hao Li, Shin-ichi Tashiro, Satoshi Onodera, Fumiaki Uchiumi, Takashi Ikejima
Format: Article
Language:English
Published: Elsevier 2006-01-01
Series:Journal of Pharmacological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861319343518
_version_ 1811199399412367360
author Bei Zhou
Li-Jun Wu
Lin-Hao Li
Shin-ichi Tashiro
Satoshi Onodera
Fumiaki Uchiumi
Takashi Ikejima
author_facet Bei Zhou
Li-Jun Wu
Lin-Hao Li
Shin-ichi Tashiro
Satoshi Onodera
Fumiaki Uchiumi
Takashi Ikejima
author_sort Bei Zhou
collection DOAJ
description Terminally differentiated adult injured cardiac myocytes have been used for various animal models of heart failure. It has recently been shown that isoproterenol induces injury in rat neonatal cardiac myocytes via a β-adrenergic pathway, suggesting that it might be one of the factors involved in myocardial cell injury in heart failure in vivo. In the study, silibinin, a plant flavanoid from milk thistle was first evaluated for its protective effect against β-adrenergic agonist isoproterenol-induced injury in cultured rat neonatal cardiac myocytes. The viability, activation of lactate dehydrogenase (LDH), and content of maleic dialdehyde (MDA) were chosen for measuring the degree of cardiac myocytes injury. As a result, silibinin protected isoproterenol-treated rat cardiac myocytes from death and significantly decreased LDH release and MDA production. Silibinin increased superoxide dismutase activity, decreased [Ca2+]i, and increased mitochondrial membrane potential (∆Ψ). Furthermore, the release of pro-apoptotic cytochrome c from mitochondria was reduced by silibinin. Silibinin increased the expression of anti-apoptotic Bcl-2 family protein Bcl-2, and up-regulation of SIRT1 inhibited the translocation of Bax from cytoplasm to mitochondria, which caused mitochondrial dysfunction and cell injury. These results demonstrate that silibinin protects against isoproterenol-induced cardiac myocytes injury through resuming mitochondrial function and regulating the expression of SIRT1 and Bcl-2 family members. Keywords:: silibinin, cardiac myocyte (rat), injury, mitochondrial membrane potential, SIRT1
first_indexed 2024-04-12T01:47:40Z
format Article
id doaj.art-e99da10e20b944e0867b575d160870a2
institution Directory Open Access Journal
issn 1347-8613
language English
last_indexed 2024-04-12T01:47:40Z
publishDate 2006-01-01
publisher Elsevier
record_format Article
series Journal of Pharmacological Sciences
spelling doaj.art-e99da10e20b944e0867b575d160870a22022-12-22T03:53:01ZengElsevierJournal of Pharmacological Sciences1347-86132006-01-011024387395Silibinin Protects Against Isoproterenol-Induced Rat Cardiac Myocyte Injury Through Mitochondrial Pathway After Up-regulation of SIRT1Bei Zhou0Li-Jun Wu1Lin-Hao Li2Shin-ichi Tashiro3Satoshi Onodera4Fumiaki Uchiumi5Takashi Ikejima6China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical University, Shenyang 110016, ChinaDepartment of Phytochemistry, Shenyang Pharmaceutical University, Shenyang 110016, ChinaChina-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical University, Shenyang 110016, ChinaDepartment of Clinical and Biomedical Sciences, Showa Pharmaceutical University, Tokyo 194-8543, JapanDepartment of Clinical and Biomedical Sciences, Showa Pharmaceutical University, Tokyo 194-8543, JapanDepartment of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, JapanChina-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical University, Shenyang 110016, China; Corresponding author. ikejimat@vip.sina.comTerminally differentiated adult injured cardiac myocytes have been used for various animal models of heart failure. It has recently been shown that isoproterenol induces injury in rat neonatal cardiac myocytes via a β-adrenergic pathway, suggesting that it might be one of the factors involved in myocardial cell injury in heart failure in vivo. In the study, silibinin, a plant flavanoid from milk thistle was first evaluated for its protective effect against β-adrenergic agonist isoproterenol-induced injury in cultured rat neonatal cardiac myocytes. The viability, activation of lactate dehydrogenase (LDH), and content of maleic dialdehyde (MDA) were chosen for measuring the degree of cardiac myocytes injury. As a result, silibinin protected isoproterenol-treated rat cardiac myocytes from death and significantly decreased LDH release and MDA production. Silibinin increased superoxide dismutase activity, decreased [Ca2+]i, and increased mitochondrial membrane potential (∆Ψ). Furthermore, the release of pro-apoptotic cytochrome c from mitochondria was reduced by silibinin. Silibinin increased the expression of anti-apoptotic Bcl-2 family protein Bcl-2, and up-regulation of SIRT1 inhibited the translocation of Bax from cytoplasm to mitochondria, which caused mitochondrial dysfunction and cell injury. These results demonstrate that silibinin protects against isoproterenol-induced cardiac myocytes injury through resuming mitochondrial function and regulating the expression of SIRT1 and Bcl-2 family members. Keywords:: silibinin, cardiac myocyte (rat), injury, mitochondrial membrane potential, SIRT1http://www.sciencedirect.com/science/article/pii/S1347861319343518
spellingShingle Bei Zhou
Li-Jun Wu
Lin-Hao Li
Shin-ichi Tashiro
Satoshi Onodera
Fumiaki Uchiumi
Takashi Ikejima
Silibinin Protects Against Isoproterenol-Induced Rat Cardiac Myocyte Injury Through Mitochondrial Pathway After Up-regulation of SIRT1
Journal of Pharmacological Sciences
title Silibinin Protects Against Isoproterenol-Induced Rat Cardiac Myocyte Injury Through Mitochondrial Pathway After Up-regulation of SIRT1
title_full Silibinin Protects Against Isoproterenol-Induced Rat Cardiac Myocyte Injury Through Mitochondrial Pathway After Up-regulation of SIRT1
title_fullStr Silibinin Protects Against Isoproterenol-Induced Rat Cardiac Myocyte Injury Through Mitochondrial Pathway After Up-regulation of SIRT1
title_full_unstemmed Silibinin Protects Against Isoproterenol-Induced Rat Cardiac Myocyte Injury Through Mitochondrial Pathway After Up-regulation of SIRT1
title_short Silibinin Protects Against Isoproterenol-Induced Rat Cardiac Myocyte Injury Through Mitochondrial Pathway After Up-regulation of SIRT1
title_sort silibinin protects against isoproterenol induced rat cardiac myocyte injury through mitochondrial pathway after up regulation of sirt1
url http://www.sciencedirect.com/science/article/pii/S1347861319343518
work_keys_str_mv AT beizhou silibininprotectsagainstisoproterenolinducedratcardiacmyocyteinjurythroughmitochondrialpathwayafterupregulationofsirt1
AT lijunwu silibininprotectsagainstisoproterenolinducedratcardiacmyocyteinjurythroughmitochondrialpathwayafterupregulationofsirt1
AT linhaoli silibininprotectsagainstisoproterenolinducedratcardiacmyocyteinjurythroughmitochondrialpathwayafterupregulationofsirt1
AT shinichitashiro silibininprotectsagainstisoproterenolinducedratcardiacmyocyteinjurythroughmitochondrialpathwayafterupregulationofsirt1
AT satoshionodera silibininprotectsagainstisoproterenolinducedratcardiacmyocyteinjurythroughmitochondrialpathwayafterupregulationofsirt1
AT fumiakiuchiumi silibininprotectsagainstisoproterenolinducedratcardiacmyocyteinjurythroughmitochondrialpathwayafterupregulationofsirt1
AT takashiikejima silibininprotectsagainstisoproterenolinducedratcardiacmyocyteinjurythroughmitochondrialpathwayafterupregulationofsirt1